Boston Scientific Enters Renal Denervation Market Via Vessix Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Deal gives Boston Scientific access to the V2 radiofrequency energy-based renal denervation catheter system for drug-resistant hypertension.